|
|
|
Insider
Information: |
Bodick Neil |
Relationship: |
Chief Scientific Officer |
City: |
Burlington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
100,153 |
|
Indirect Shares
|
389,683 |
|
|
Direct
Value |
$913,395 |
|
|
Indirect Value
|
$3,553,909 |
|
|
Total
Shares |
489,836 |
|
|
Total
Value |
$4,467,304 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Flexion Therapeutics Inc |
FLXN |
Chief Scientific Officer |
2020-01-03 |
100,153 |
2020-01-03 |
389,683 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2018-10-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,566 |
66,873 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2018-10-08 |
4 |
D |
$18.60 |
$25,017 |
D/D |
(1,345) |
65,528 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2019-01-03 |
4 |
AS |
$12.36 |
$9,221 |
D/D |
(746) |
64,782 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
100,782 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2019-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,568 |
105,350 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2019-10-07 |
4 |
D |
$13.98 |
$18,817 |
D/D |
(1,346) |
104,004 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
|
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,851) |
100,153 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-02-24 |
4/A |
AS |
$19.15 |
$95,758 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-02-24 |
4/A |
OE |
$2.52 |
$10,081 |
D/D |
4,000 |
64,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-03-17 |
4/A |
OE |
$2.52 |
$12,602 |
D/D |
5,000 |
64,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-03-17 |
4/A |
AS |
$20.41 |
$102,038 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-04-17 |
4/A |
AS |
$28.20 |
$141,132 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-04-17 |
4/A |
OE |
$2.52 |
$12,602 |
D/D |
5,000 |
64,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-05-15 |
4/A |
AS |
$18.81 |
$129,448 |
D/D |
(6,830) |
59,937 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
|
2017-05-15 |
4/A |
OE |
$2.52 |
$17,214 |
D/D |
6,830 |
66,767 |
0 |
- |
|
40 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|